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Abstract
Introduction: Systemic inflammation in sepsis is initiated by interactions between pathogen molecular motifs and
specific host receptors, especially toll-like receptors (TLRs). Flagellin is the main flagellar protein of motile
microorganisms and is the ligand of TLR5. The distribution of TLR5 and the actions of flagellin at the systemic level
have not been established. Therefore, we determined TLR5 expression and the ability of flagellin to trigger
prototypical innate immune responses and apoptosis in major organs from mice.
Methods: Male Balb/C mice (n = 80) were injected intravenously with 1-5 μg recombinant Salmonella flagellin.
Plasma and organ samples were obtained after 0.5 to 6 h, for molecular investigations. The expression of TLR5, the
activation state of nuclear factor kappa B (NFB) and mitogen-activated protein kinases (MAPKs) [extracellular
related kinase (ERK) and c-jun-NH2 terminal kinase (JNK)], the production of cytokines [tumor necrosis alpha (TNFa),
interleukin-1b (IL-1b), interleukin-6 (IL-6), macrophage inhibitory protein-2 (MIP-2) and soluble triggering receptor
expressed on myeloid cells (TREM-1)], and the apoptotic cleavage of caspase-3 and its substrate Poly(ADP-ribose)
polymerase (PARP) were determined in lung, liver, gut and kidney at different time-points. The time-course of
plasma cytokines was evaluated up to 6 h after flagellin.
Results: TLR5 mRNA and protein were constitutively expressed in all organs. In these organs, flagellin elicited a
robust activation of NFB and MAPKs, and induced significant production of the different cytokines evaluated, with
slight interorgan variations. Plasma TNFa, IL-6 and MIP-2 disclosed a transient peak, whereas IL-1b and soluble
TREM-1 steadily increased over 6 h. Flagellin also triggered a marked cleavage of caspase-3 and PARP in the
intestine, pointing to its ability to promote significant apoptosis in this organ.
Conclusions: Bacterial flagellin elicits prototypical innate immune responses in mice, leading to the release of
multiple pro-inflammatory cytokines in the lung, small intestine, liver and kidney, and also activates apoptotic
signalling in the gut. Therefore, this bacterial protein may represent a critical mediator of systemic inflammation
and intestinal barrier failure in sepsis due to flagellated micro-organisms.
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Introduction
Systemic inflammation and multiple organ dysfunction
during Gram-negative sepsis have been largely attributed
to the activation of innate immune defenses by lipopoly-
saccharide (LPS) [1]. Accordingly, recent studies showed
that strategies interfering with LPS-dependent signaling,
including myeloid-differentiation factor-2 [2] and toll-
like receptor (TLR) 4 (TLR4) [1] proved beneficial in
experimental Gram-negative sepsis. In addition to LPS,
most enteric Gram-negative bacteria also release sub-
stantial amounts of flagellin, the main structural protein
from the bacterial flagellum [3]. Flagellin binds to TLR5
[4] and activates the pro-inflammatory transcription fac-
tor nuclear factor (NFB) in various epithelial cells,
endothelial cells and leukocytes in vitro (see [3] for
review). In vivo, the flagellin-TLR5 axis has been asso-
ciated with the development of cardiovascular collapse
[5], acute lung inflammation [6] and inflammatory
bowel diseases [7] in mice. Importantly, significant con-
centration of flagellin circulate in the plasma of human
patients with Gram-negative sepsis [6], suggesting that it
might represent a significant pro-inflammatory bacterial
protein in this setting.
Therefore, the present study was designed to deter-
mine the distribution of TLR5 in major organs of mice
(lung, liver, kidney and intestine), and to evaluate the
ability of these organs to mount an innate immune
response to exogenously administered recombinant fla-
gellin. Our main findings indicate that TLR5 is
expressed by all the organs examined, and that flagellin
elicits prototypical immune signaling in these organs,
characterized by the activation of NFB and mitogen-
activated protein kinases (MAPKs), as well as the pro-
duction of multiple inflammatory cytokines, and also
that flagellin initiates proapoptotic responses predomi-
nantly in the intestine. Thus, flagellin/TLR5 signaling
elicits several mechanisms that are instrumental in the
pathophysiology of sepsis, and might therefore represent
a novel target for therapeutic intervention.
Materials and methods
Administration of flagellin to conscious mice
All procedures conformed to the Swiss laws on the care
and use of laboratory animals and were approved by our
local ethical committee for animal experimentation.
Male BALB/c mice (weighing 23 to 26 g) were injected
(tail vein) with recombinant Salmonella muenchen fla-
gellin (Calbiochem, San Diego, CA, USA), given at doses
of 1 or 5 μg/mouse. Such doses are pathophysiologically
and clinically relevant, because free flagellin, at up to
several hundred μg/L, is detectable in the plasma of rats
with lethal Gram-negative bacteria-induced peritonitis
[5], and free flagellin circulates at levels between 2 and
20 μg/L in the blood of patients with Gram-negative
sepsis [6]. Flagellin was suspended in a volume of 0.2 ml
isotonic saline. Sham animals injected with saline only
were used for control purposes. The flagellin prepara-
tion was devoid of LPS contamination, as indicated by
the Limulus assay (< 0.0003 μg LPS/μg flagellin). At
selected time-points (30 minutes to 6 hours), mice were
sacrificed by pentobarbital overdose, and the lung, liver,
small intestine and kidney were removed for subsequent
analyses. Plasma was collected for the measurement of
cytokines.
RNA Isolation, RT-PCR and quantitative real-time PCR
Total RNA from tissues was isolated by TRIzol reagent
(Invitrogen, Basel, Switzerland). RNA was reverse-tran-
scribed to cDNA and amplified by PCR (One-step RT-
PCR kit from Qiagen, Hombrechtikon, Switzerland). A
kit of mouse-specific PCR primers was purchased for
TLR5 (R&D Systems, Minneapolis, MN, USA). GAPDH
was used for control purposes. The cDNAs were further
subjected to quantitative real-time PCR using the SYBR
Premix Ex Taq (Takara Bio Inc., Otsu, Shiga, Japan) on
a LightCycler Instrument (Roche Applied Science, Rotk-
reuz, Switzerland). Cycling conditions consisted of an
initial denaturating step at 95°C (20 seconds) followed
by 45 cycles of a thermal step protocol consisting of 95°
C (30 seconds), 60°C (20 seconds). Primer sequences for
TLR 5 were 5’-CCA CCG AAG ACT GCG ATG A-3’
and 5’-GTG ACC GTG CAC AGG ATG AA-3’. The
data obtained for TLR5 were normalized to the level of
18 S (5’-ACT TTT GGG GCC TTC GTG TC-3’; 5’-
GCC CAG AGA CTC ATT TCT TCT TG-3’), and
expressed in fold augmentation with respect to the
expression in the kidney (which had the weakest
expression).
Protein extraction and immunoblot analyses
Tissues were homogenized in ice-cold lysis buffer, and
cytoplasmic and nuclear proteins were obtained as
described [8]. Proteins (20 to 80 μg) were separated by a
standard SDS-PAGE procedure. The following antibo-
dies were used for immunoblotting: anti-inhibitor of
kappaB alpha (IBa), anti-phospho-IBa, anti-c-jun-
NH2 terminal kinase (JNK)1, anti-extracellular related
kinase (ERK)1/2 (all from Santa-Cruz Biotechnology,
Santa Cruz, CA, USA), anti-phospho-JNK1/2, anti-phos-
pho-ERK1/2, anti-poly(ADP-ribose) polymerase (PARP),
anti-caspase-3, anti-cleaved-caspase-3 (all from Cell Sig-
naling, Beverly, MA, USA), anti-b-actin, anti-a-tubulin
(Sigma-Aldrich, Basel, Switzerland) and anti-TLR5 (Bio-
vision Inc., Mountain View, CA, USA). The immunoblot
signals were visualized using enhanced chemilumines-
cence (ECL, Amersham Biosciences, Otelfingen, Switzer-
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land). Densitometric analysis was performed using a
Personal Densitometer TM (Molecular Dynamics, Sun-
nyvale, CA, USA) and TotalLab software (TotalLab,
Newcastle upon Tyne, UK), as described [9].
Electromobility shift assay
Electromobility shift assay (EMSA) was performed as
described [8], by incubating 10 μg of nuclear proteins
with an NFB oligonucleotide probe (5’-GGCAGTT-
GAAGGGGACTTTCCCAGG-3’) labeled with a-
32PdCTP, and poly dIdC for 20 minutes. For supershift
assays, the nuclear extracts were preincubated for 30
minutes on ice with an anti-p65 or an anti-p50 antibody
(both from Cell Signaling, Beverly, MA, USA) before
adding the radioactive probe. Samples were resolved on
a non-denaturing polyacrylamide gel. Gels were trans-
ferred to Whatman 3 M paper (Fisher Scientific, Woh-
len, Switzerland), dried under vacuum, and exposed to
photographic film at -70°C with intensifying screens.
Quantification of cytokine production
The tissue concentrations of TNFa, IL-1b, IL-6, macro-
phage-inhibitory protein (MIP)-2 and soluble triggering
receptor expressed on myeloid cells (sTREM-1) were
measured in tissue homogenates using commercially
available ELISA kits (R&D Systems, Minneapolis, MN,
USA) according to manufacturer’s protocol. The same
cytokines were also measured in plasma.
Presentation of data and statistical analysis
All graphs summarize the results of at least three inde-
pendent experiments, and are presented as means ±
standard error of the mean. In experiments comparing
only two conditions, statistical analysis was performed
with Student’s t test. In experiments using multiple con-
ditions, comparison was performed with analysis of var-
iance. When the F value was significant at the 5% level,
further pair-wise comparisons were made between fla-
gellin and control conditions using Dunnett’s test. A P
value less than 0.05 was considered significant.
Results and discussion
TLR5 is expressed in mouse lung, liver, small intestine
and kidney
The specific mammalian ligand of flagellin is TLR5 [4].
Our first aim was thus to determine the tissue expres-
sion of TLR5 in mice. As illustrated in Figure 1, both
TLR5 mRNA (Figures 1a and 1b) and protein (Figure
1c) were detected in all organs evaluated, implying their
ability to sense extracellular flagellin. These observations
extend previous works, including our own, which identi-
fied TLR5 mRNA in various mammalian tissues [10],
and TLR5 protein expression in the intestine [7] and
myocardium [11]. Of note, quantitative PCR indicated
that TLR5 mRNA expression was highest in the lung
and liver. Such a high degree of TLR5 expression might
be essential for the early detection of invading air-borne
or blood-borne flagellated micro-organisms, as proposed
previously [12]. Another finding was that TLR5 expres-
sion did not increase up to three hours after the admin-
istration of flagellin (as evaluated in the lung, Figure
1d), pointing to the lack of inducibility of TLR5 in the
presence of its ligand.
Flagellin diffusely activates NFB and MAP kinase
signaling in tissues
The widespread expression of TLR5 indicates that the
examined organs might have the ability to mount innate
immune defense mechanisms upon the recognition of
circulating flagellin. It is known that TLR-dependent
immune responses mostly rely on the activation of the
key transcription factor NFB, a family of dimeric tran-
scription factors, normally held in the cytoplasm of
quiescent cells, bound to an inhibitory protein, IBa
[13]. NFB activation relies on stimulus-induced IBa
phosphorylation and proteasomal degradation, allowing
free NFB to translocate into the nucleus and to bind to
its response element on the DNA [13]. As shown in Fig-
ure 2, flagellin (1 μg/mouse) induced significant IBa
phosphorylation and degradation after 30 minutes in the
different tissues examined. In the lung, the degradation
appeared less pronounced, probably reflecting a larger
pool of total IBa, making the degradation more diffi-
cult to detect.
Further evidence of NFB activation is indicated in
Figure 3, showing the results of NFB-DNA binding
experiments by EMSA. Within 30 minutes, flagellin trig-
gered a robust increase of NFB-DNA binding, an effect
that was particularly marked in the liver, with more
than a 60-fold increase compared with control condi-
tions (Figure 3a). Interestingly, the positions of the
shifted bands were different in the liver than in the
other organs. As NFB is a family of heterodimeric (and
homodimeric) proteins that include p50 (and its precur-
sor p105), p52 (and its precursor p100), p65, RelB, and
c-Rel, this observation suggests that the composition of
the NFB dimer in the liver differs from the other
organs. Given that the most common dimer is formed
from a p50 and p65 subunit, we performed supershift
experiments using anti-p50 and anti-p65 antibodies. As
shown in Figure 3b, the bands were supershifted only by
the anti-p65 antibody, implying that the NFB complex
contains significant amounts of p65 in all organs
exposed to flagellin. The liver disclosed an additional
large shifted band, which did not supershift in the pre-
sence of anti-p50 and anti-p65, further supporting a dis-
tinct hetero-or homodimeric composition of NFB in
this organ.
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These findings are the first to formally demonstrate
the ability of flagellin, at very low concentrations, to
promote diffuse NFB activation in vivo. It is noticeable
that the degree of NFB activation was the smallest in
the lungs and intestines, which may indicate that organs
naturally exposed to environmental micro-organisms
have developed specific mechanisms to down-regulate
TLR5-dependent signaling in order to prevent over-
whelming and permanent inflammatory responses, an
issue that should be addressed in future studies.
Besides NFB, TLRs also signal through the MAPK
cascade, especially the stress-activated protein kinase
Figure 1 Tissue expression of TLR5. (a) Constitutive expression of TLR5 mRNA (RT-PCR) in mouse lung, liver, gut and kidney. C-, negative
control (no RNA); C+, positive control of the TLR5 primer kit. Sizes of the amplified fragments were 310 base pairs for positive control and 381
base pairs for TLR5. GAPDH, loading control. (b) Quantitative TLR5 mRNA expression in mouse lung, liver, gut and kidney. In each organ, TLR5
mRNA was normalized to the levels of 18 S. The expression of TLR5 is shown relative to the kidney, and is indicated above each column. (c)
TLR5 protein expression was determined by immunoblotting with b-actin shown as a loading control. (d) Expression of TLR5 protein
(immunoblot) in the lung under baseline conditions (0 h), and one (1 h) and three (3 h) hours after the administration of flagellin (5 μg). There
was no evidence of TLR5 induction upon flagellin. Results, shown in duplicates, are representative of at least three independent experiments.
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JNK and ERK [14]. Figure 4 shows that flagellin pro-
moted strong phosphorylation of JNK in the lung and
liver, contrasting with a weak activation in the gut and
kidney. With respect to ERK, its phosphorylation was
enhanced in the lung, gut and kidney, and less in the
liver, in which ERK was already phosphorylated under
baseline conditions. These novel observations point to
significant organ specificity in the modulation of TLR5-
dependent signaling in response to flagellin, a feature
also observed with other bacterial components triggering
innate immune responses, such as peptidoglycan [15].
The mechanisms underlying such organ-specific
responses cannot be determined from our current data
and thus will need further investigations.
It is worth mentioning that an increase in the dose of
flagellin to 5 μg/mouse did not exert any further
increase in the activation of MAPKs and NFB, as
shown by a comparable degree of ERK and IBa phos-
phorylation in the different organs (Figure 5), suggesting
that minute doses of flagellin are already sufficient to
produce a maximal activation of these stress signaling
cascades. This observation is consistent with the marked
pro-inflammatory potency of flagellin, which has been
shown to induce a pro-inflammatory response in the
lung at a threshold of 10 ng/mouse [6]. A further find-
ing was the transient nature of the process of immune
activation triggered by flagellin, as indicated by the
absence of sustained phosphorylation of ERK and IBa
six hours after the injection of flagellin (Figure 5). This
time-course is indeed typical of the usual short-lived
pattern of MAPKs and NFB activation due to the rapid
induction of negative feedback regulatory mechanisms
[5,16-18]. Such balance between immune activation and
subsequent deactivation is critical to eliminate invading
Figure 2 Flagellin triggers IBa phosphorylation and degradation in mouse organs. Phosphorylation of inhibitor of kappaB alpha (IBa),
associated with IBa degradation, 30 minutes after flagellin (1 μg/mouse) or saline (sham) in mouse lung, liver, gut and kidney; a-tubulin and
b-actin, loading controls. Densitometric analysis, * P < 0.05 flagellin vs sham, t-test (n = 5 mice/group).
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pathogens, while at the same time restraining the risk of
self-destruction by unopposed inflammatory responses
[18].
Flagellin promotes widespread generation of
inflammatory cytokines
The activation of TLRs ultimately results in the
enhanced expression of multiple inflammatory media-
tors [19], which stand at the foreground of the systemic
inflammation and multiple organ dysfunction character-
izing septic shock [20]. Accordingly, the activation of
innate immune signaling by flagellin translated into the
establishment of a pro-inflammatory phenotype in the
organs examined, as shown by the up-regulated expres-
sion of the cytokines TNFa, IL-1b, IL-6, sTREM-1, and
the chemokine MIP-2 (the rodent equivalent of human
IL-8) in these organs (Figure 6), as well as in plasma
(Figure 7), after flagellin administration. Similarly to the
activation of NFB and ERK discussed above, the rise in
plasma cytokines (at least for TNFa, IL-6 and MIP-2)
was similar at 1 or 5 μg, further supporting the consid-
erable pro-inflammatory potency of this bacterial pro-
tein. In spite of this diffuse inflammatory response, it is
worth mentioning that the doses of flagellin used in this
study were not lethal, as indicated by the lack of any
mortality observed up to 48 hours after flagellin
administration.
The production of cytokines followed two distinct
time-courses. First, TNFa, IL-6 and MIP-2 in tissues
showed an early peak after one hour and a steady
decline thereafter, with a return to baseline concentra-
tions at three hours (for TNFa and IL-6). A noticeable
exception was the lung, in which IL-6 did not show any
increase over time after flagellin, but it is noteworthy
that the concentration of IL-6 was already elevated
under baseline conditions in this organ, an observation
Figure 3 Flagellin induces NF-B-DNA binding in the lung, liver, gut and kidney. (a) Nuclear factor (NF)-B-DNA binding activity
(electromobility shift assay (EMSA)) in mouse tissues 30 minutes after flagellin (1 μg/mouse) or saline (sham). (b) Supershift experiments. Nuclear
proteins were incubated with an anti-p50 or an anti-p65 antibody prior to incubation with the radioactive probe. In all organs, the shifted bands
supershifted in the presence of anti-p65. A large shifted band, which was not affected by anti-p65 and anti-p50 was detected in the liver.
Densitometric analysis, * P < 0.05 flagellin vs sham, t-test (n = 5 mice/group).
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already reported by others [21,22]. In plasma, TNFa
increased only transiently, with a peak at one hour fol-
lowed by return to baseline values at later time-points.
IL-6 and MIP-2 also peaked after one hour, but were
still significantly elevated at three and six hours. Such
profile is comparable with the hyperacute cytokine
response, which is observed following the administration
of LPS both in animals [23] and humans [24].
A second, distinct time-course was observed for IL-1b
and sTREM-1, which remained elevated after three hours
in the organs and were still significantly increased in the
plasma six hours after the flagellin challenge. TREM-1,
expressed at the surface of neutrophils and a subset of
monocytes [25], is released as a soluble form in the plasma
during sepsis and endotoxemia with a time-course similar
to the one noted in the current study [26]. With respect to
IL-1b, it must be underscored that its expression does not
rely on NF-B signaling, but instead on the activation of
caspase-1 and inflammasome-dependent processing of
pro-IL-1b [27]. Inflammasomes are high-molecular weight,
caspase-1-activating platforms that control maturation and
secretion of IL-1b, which are assembled upon activation of
intracellular receptors by various microbial and host-
derived danger signals. These receptors belong to the
Figure 4 Flagellin activates MAPK signaling pathway in mouse organs. Mitogen-activated protein kinase (MAPK) activation, evaluated by
the phosphorylation state of c-jun-NH2 terminal kinase (JNK) and extracellular related kinase (ERK), in mouse organs 30 minutes after the
injection of flagellin (1 μg/mouse) or saline (sham). Phosphorylation of JNK was detected in the lung, liver, and gut, but not the kidney. ERK
phosphorylation was present in the lung, gut and kidney, but not in the liver. Total JNK and ERK signals were not influenced by flagellin; a-
tubulin, loading controls. Blots, shown in duplicates, are representative of at least three independent experiments.
Figure 5 Transient nature of mitogen-activated protein kinase and nuclear factor-B activation in response to flagellin. The
phosphorylation state of extracellular related kinase (ERK) and inhibitor of kappaB alpha (IBa) was evaluated by immunoblotting in organs from
mice under baseline conditions (Control C) and from mice challenged with 5 μg of flagellin for 30 minutes or 6 hours. The phosphorylation
noted at 30 minutes did not persist after 6 hours. Blots are representative of three independent experiments.
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nucleotide binding oligomerization domain (NOD)-like
receptor family, consisting of the NODs, the NOD-like
receptor proteins (NLRPs) and the interleukin-1-convert-
ing enzyme protease-activating factor (IPAF) subfamilies.
The IPAF inflammasome is activated by cytosolic flagellin
(in contrast to the recognition of extracellular flagellin by
TLR5), which is injected into the cytosol via bacterial type
III and IV secretion systems. The increased expression of
IL-1b observed in our study is therefore consistent with
the activation of the IPAF inflammasome by flagellin
[28-30]. In summary, the time-course of the different cyto-
kines reported in the current study support the concept
that flagellin triggers an early, diffuse and transient pro-
inflammatory response, that is followed by the activation
of mononuclear cells, promoting a long-lasting secondary
response characterized by persistent elevation of sTREM-1
and IL-1b.
Flagellin differentially triggers apoptotic signaling in
mouse organs
Multiple organ dysfunction in sepsis generally occurs in
the absence of significant apoptosis or necrosis in the
failing organs, except from the gut, in which extensive
apoptosis of epithelial cells has been reported [31].
Apoptosis in the gut may be particularly detrimental in
sepsis by compromising bowel wall integrity, as sug-
gested by studies reporting significantly reduced sepsis
mortality in transgenic mice overexpressing the antia-
poptotic protein Bcl-2 in their intestinal epithelium
[32,33]. Here we sought to determine the ability of fla-
gellin to initiate apoptotic signaling in mouse organs, by
determining the degree of activation of capase-3, one of
the major executioner caspases, and the cleavage of its
substrate PARP [34].
As illustrated in Figure 8, flagellin triggered only tran-
sient caspase-3 and PARP cleavage in the lung and liver,
pointing to limited apoptosis and rapid clearance of
apoptotic cells in these organs. In the kidney, except
from a slight cleavage of PARP at one hour, apoptotic
changes were virtually absent. These observations are
totally consistent with the low degree of apoptosis
reported in the liver, lung and kidney during sepsis [35].
In marked contrast, significant apoptotic changes were
present in the gut, as indicated by a very strong cleavage
Figure 6 Flagellin triggers the diffuse expression of pro-inflammatory cytokines. Levels of inflammatory cytokines, measured by ELISA, in
(a) lung, (b) liver, (c) gut and (d) kidney, at baseline and one and three hours after flagellin administration (5 μg/mouse). * P < 0.05 versus
baseline (analysis of variance followed by Dunnett’s test, n = 5 to 6 mice/group).
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of both caspase-3 and PARP, three hours after flagellin
administration. It is particularly noteworthy that a pre-
vious study indicated that apoptosis within the gut dur-
ing polymicrobial sepsis is endotoxin-independent [36].
Thus, our findings suggest that flagellin might represent
an important culprit of these changes in this setting.
Study limitations
The different measurements in our study were per-
formed at the level of whole organs containing multiple
cell populations (parenchymal, vascular and inflamma-
tory cells). Therefore, we cannot comment further on
the respective implication of each of these cell types in
the observed effects of flagellin. Further studies using
histochemical labeling would be necessary to address
this issue. A second limitation is the lack of direct com-
parisons between the effects of flagellin and endotoxin
in our study. However, due to the extensive documenta-
tion of the effects of endotoxin in the murine model, we
opted to focus primarily on the systemic effects of fla-
gellin, which have remained so far largely unexplored.
Thirdly, with respect to apoptosis, we only relied on
molecular markers and thus, we cannot provide direct
quantification of the severity of apoptosis in the differ-
ent organs evaluated, which would require further
immunohistochemical studies.
Conclusions
In conclusion, the data presented herein are the first to
formally demonstrate that TLR5 is widely expressed in
mouse organs in vivo, that flagellin elicits prototypical
innate immune responses in these organs, and that it
also activates apoptotic signaling, predominantly in the
intestine. These findings imply that flagellin may be
Figure 7 Time-course of plasma cytokines after flagellin administration. Cytokines were quantified by ELISA in plasma at baseline (time 0),
at one, three and six hours after 5 μg flagellin, and at one and three hours after 1 μg flagellin in separate groups of mice (n = 5 to 6 mice/
group). An early peak (1 h) was noted for TNFa, IL-6 and macrophage-inhibitory protein-2 (MIP-2), whereas IL-1b and soluble triggering receptor
expressed on myeloid cells (sTREM-1) steadily increased over six hours. * P < 0.05 versus baseline (analysis of variance followed by Dunnett’s
test).
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instrumental in the pathogenesis of Gram-negative sep-
sis. Hence, the therapeutic potential of anti-flagellin or
anti-TLR5 strategies in this setting should be tested in
the future.
Key messages
• TLR5, the specific mammalian receptor for bacter-
ial flagellin, is expressed in the lung, kidney, liver
and small intestine of mice, both at the mRNA and
protein level.
• Recombinant Salmonella flagellin elicits wide-
spread innate immune responses in mouse organs,
characterized by the activation of NF-B and
MAPKs.
•The innate immune response to bacterial flagellin
promotes systemic inflammation and triggers apop-
totic signalling in the intestine.
• Flagellin/TLR5 signaling may be instrumental in
the pathogenesis of Gram-negative sepsis.
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